San Francisco, CA, United States of America

Denise M Kenski

This inventor holds 12 USPTO granted patents and 1 published patent application and 6 EPO patents. Top assignees: Sirna Therapeutics, Inc., Genentech, Inc.. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Denise M Kenski. Retrieved from https://idiyas.com/inventor/denise-m-kenski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.8

ph-index = 4

Forward Citations = 97(Granted Patents)


Company Filing History:


Years Active: 2014-2026

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Denise M Kenski: Pioneering Innovations in RNA Interference

Introduction:

Denise M Kenski, a visionary inventor based in San Francisco, CA, is a trailblazer in the field of RNA interference. With a profound passion for innovation and a relentless drive to make a positive impact on the world, she continues to inspire generations of inventors and entrepreneurs.

Latest Patents:

Denise M Kenski holds an impressive portfolio of 10 patents, with her latest inventions focusing on RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA). These breakthrough compounds, compositions, and methods open new avenues for the study, diagnosis, and treatment of various traits, diseases, and conditions that respond to the modulation of gene expression pathways.

Career Highlights:

Throughout her career, Denise M Kenski has made significant contributions to the field of biotechnology. She has worked with esteemed companies such as Sirna Therapeutics, Inc. and Genentech, Inc., leveraging her expertise to drive innovation and transformative research in the realm of RNA interference.

Collaborations:

Denise M Kenski has collaborated with notable peers in the industry, including Aarron T Willingham and William Michael Flanagan. Together, they have synergized their talents and knowledge to push the boundaries of scientific discovery and technological advancement in the biotech sector.

Conclusion:

Denise M Kenski's unwavering dedication to advancing the field of RNA interference underscores her status as a luminary inventor. Her groundbreaking work not only shapes the present landscape of biotechnology but also paves the way for a brighter, more innovative future. As her inventions continue to make waves in the scientific community, Denise M Kenski's legacy serves as a beacon of inspiration for aspiring inventors and entrepreneurs worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…